Annexon, Inc. (ANNX)
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
Address
1400 SIERRA POINT PARKWAY
BRISBANE, CA 94005
Founded
2011
Number of Employees
71
Website
http://www.annexonbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)